全球晶片器官市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計晶片器官市場將從 2025 年的 2.2865 億美元成長到 2034 年的 35.6295 億美元，2026 年至 2034 年的複合年成長率為 35.68%。

受生物醫學研究和藥物開發進展的推動，全球器官晶片市場正經歷快速成長。器官晶片技術可在微流體裝置上模擬人體器官功能，進而達到更精準的臨床前試驗。對動物試驗替代方案和更完善的藥物安全性評估的需求不斷成長，也推動了市場擴張。生技和製藥領域研發投入的增加，進一步加速了技術創新。

關鍵成長要素包括對個人化醫療和精準藥物篩檢的日益重視。製藥公司正在採用晶片器官平台來縮短研發時間並降低成本。微加工和生物材料技術的進步正在提升設備的性能。學術機構和研究組織也在投資這項技術，用於疾病建模和毒性測試。

展望未來，生物技術公司與研究機構之間日益增強的商業化和合作預計將對市場產生積極影響。在癌症研究和再生醫學領域的應用拓展將創造新的機會。多器官晶片系統的持續創新將提高預測準確性。隨著對符合倫理且高效的藥物測試方法的需求不斷成長，全球器官晶片市場預計將迎來強勁的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球晶片器官市場：依產品和服務分類

• 市場分析、洞察與預測
• 產品
• 服務

第5章：全球晶片器官市場：依應用分類

• 市場分析、洞察與預測
• 藥物發現
• 毒理學調查
• 其他

第6章：全球晶片器官市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究機構
• 製藥和生物技術公司
• 其他

第7章：全球晶片器官市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Emulate Inc
  • MIMETAS BV
  • Valo Health
  • Nortis Inc
  • AxoSim Inc
  • BICO Group AB（The Bio Convergence Company）
  • CN Bio Innovations Ltd
  • SynVivo Inc
  • The Charles Stark Draper Laboratory Inc
  • AlveoliX AG

The Organ On A Chip Market size is expected to reach USD 3562.95 Million in 2034 from USD 228.65 Million (2025) growing at a CAGR of 35.68% during 2026-2034.

The Global Organ On A Chip Market is experiencing rapid growth driven by advancements in biomedical research and drug development. Organ-on-a-chip technology replicates human organ functions on microfluidic devices, enabling more accurate preclinical testing. Increasing demand for alternatives to animal testing and improved drug safety evaluation is supporting market expansion. Rising research funding in biotechnology and pharmaceutical sectors is further accelerating innovation.

Key growth drivers include the growing focus on personalized medicine and precision drug screening. Pharmaceutical companies are adopting organ-on-a-chip platforms to reduce development timelines and costs. Technological advancements in microfabrication and biomaterials are enhancing device performance. Academic institutions and research organizations are also investing in this technology for disease modeling and toxicity testing.

Looking ahead, the market is expected to benefit from increased commercialization and collaboration between biotech firms and research institutions. Expanding applications in cancer research and regenerative medicine will create new opportunities. Continuous innovation in multi-organ chip systems will improve predictive accuracy. As demand for ethical and efficient drug testing methods rises, the Global Organ On A Chip Market is poised for strong long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Service

• Products
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End Use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Emulate Inc, MIMETAS BV, Valo Health, Nortis Inc, AxoSim Inc, BICO Group AB The Bio Convergence Company, CN Bio Innovations Ltd, SynVivo Inc, The Charles Stark Draper Laboratory Inc, AlveoliX AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGAN ON A CHIP MARKET: BY PRODUCT AND SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGAN ON A CHIP MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Toxicology Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGAN ON A CHIP MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGAN ON A CHIP MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Service
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Service
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Service
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Service
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Service
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORGAN ON A CHIP INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Emulate Inc
  • 9.2.2 MIMETAS B.V
  • 9.2.3 Valo Health
  • 9.2.4 Nortis Inc
  • 9.2.5 AxoSim Inc
  • 9.2.6 BICO Group AB (The Bio Convergence Company)
  • 9.2.7 CN Bio Innovations Ltd
  • 9.2.8 SynVivo Inc
  • 9.2.9 The Charles Stark Draper Laboratory Inc
  • 9.2.10 AlveoliX AG